Health
COVID-19 vaccine study has a warning for people who take common IBD drug – SlashGear
A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vaccine dose may be lower…
A new study is alerting people who take a common drug for Irritable Bowel Disease (IBD) that their body’s response to the first COVID-19 vaccine dose may be lower than expected. The issue was observed in people taking an immune-suppressing drug called infliximab, which is commonly prescribed for IBD.
Vaccines, including the COVID-19 vaccine, work by triggering the patient’s own immune system, resulting in the development of antibodies that help protect the individual from an infection caused by…
-
General6 hours agoFerries and celebrities as pollies dash to win the west
-
Noosa News11 hours agoCSIRO, winemakers pair to breed mildew, climate-resistant grapevines
-
Noosa News15 hours agoSpinach salads back on supermarket shelves amid E. coli probe
-
Business16 hours ago$10,000 invested in Telstra shares at Christmas is now worth